Global Cardiovascular Health Supplements Market Size study, by Type (Natural Supplements, Synthetic Supplements), by Ingredients (Vitamins and Minerals, Herbal Extracts, Others), by Dosage Form (Tablets, Capsules, Others), by Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, Online Pharmacies, Others) and Regional Forecasts 2022-2032
Global Cardiovascular Health Supplements Market is valued at approximately USD 11.11 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 6 % over the forecast period 2024-2032. Cardiovascular health supplements aid in the maintenance of an individual’s heart health by lowering cholesterol and improving blood pressure, which if not addressed can cause the risk of heart disease. These supplements include dietary supplements containing essential nutrients, such as fish oil, omega-3 fatty acids, red yeast rice, and others for a heart-healthy lifestyle. It also consists of natural herbal ingredients, such as fiber, sterols, coenzyme Q10 (CoQ10), and flaxseed oil.
The rising prevalence of heart-related disorders due to unhealthy lifestyles is majorly contributing to the cardiovascular health supplements market growth. In addition, the increasing focus of the aging population on adopting high-quality conventional supplements for improving their heart health and preventing further complications related to heart diseases is also augmenting the market growth. According to an article published by the American Academy of Family Physicians in September 2022, every year, 605,000 Americans have their first heart attack and around 610,000 experience a stroke for the first time. Furthermore, an increasing number of market players, with a strong focus on the introduction of new products to meet the growing demand, are further accelerating the growth of the heart health supplements market. Moreover, the shift towards bio-based plastics, rising consumer preference for sustainable products and market expansion across industries present various lucrative opportunities over the forecast years. However, the cost competitiveness, compliance with regulatory standards and limited recycling capabilities are challenging the market growth throughout the forecast period of 2024-2032.
The key regions considered for the Global Cardiovascular Health Supplements Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is a dominating region in the Global Cardiovascular Health Supplements Market in terms of revenue. The market growth in the region is being attributed to factors including the increasing awareness of cardiovascular diseases among the general population. Moreover, the increasing focus of dietary supplement manufacturers on collaborations with natural extract manufacturers for the development and launch of innovative products in the U.S. is further anticipated to contribute to the market’s growth in the region. Whereas, the market in Asia Pacific is anticipated to grow at the fastest rate over the forecast period fueled by the rising prevalence of hypercholesterolemia and ischemic heart disease due to changing lifestyles of the Asian population is contributing to the growing adoption of cardiovascular health supplements in the region. Moreover, the increasing number of people following their traditional practice of consuming preventive medicine will further augment the consumption of these supplements in the region.
Major market player included in this report are:Amway (U.S.)
Thorne (U.S.)
Swisse Wellness Pty Ltd (Australia)
Herbalife International of America, Inc. (India)
BL Bio Lab, LLC. (U.S.)
Church & Dwight Co., Inc. (U.S.)
Vyta Health Limited. (Netherlands)
Gaia Herbs (U.S.)
Herb Pharm (U.S.)
Abbott Laboratories
Nature's Bounty Co.
GNC Holdings, LLC
Pfizer Inc.
Garden of Life, LLC
Himalaya Global Holdings Ltd.
The detailed segments and sub-segment of the market are explained below:By Type:
Natural Supplements
Synthetic Supplements
By Ingredients:
Vitamins and Minerals
Herbal Extracts
Others
By Dosage Form:
Tablets
Capsules
Others
By Distribution Channel:
Hospital Pharmacies
Drug Stores & Retail Pharmacies
Online Pharmacies
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
Saudi Arabia
South Africa
RoMEA
Years considered for the study are as follows:Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032
Key Takeaways:Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.